Measuring cell proliferation in the rectal mucosa

Comparing bromodeoxyuridine (BrdU) and proliferating cell nuclear antigen (PCNA) assays

Martin Kulldorff, Lisa M. McShane, Arthur Schatzkin, Laurence S. Freedman, Michael J Wargovich, Cindy Woods, Madhu Purewal, Randall W. Burt, Michael Lawson, Donna J. Mateski, Elaine Lanza, Donald K. Corle, Barbara O'Brien, James Moler

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Cell proliferation in the human colorectum can be measured using bromodeoxyuridine (BrdU) or proliferating cell nuclear antigen (PCNA) assays. Using data from the National Cancer Institute's Polyp Prevention Trial, these two assays are compared using correlation coefficients and variance components analysis. Adjusting for fixed as well as for the random effects of between-biopsy and scoring variation, the estimated correlation is 0.46 for the log labeling index and 0.45 for log proliferative height. This is an estimate of the highest correlation that can be achieved by taking multiple biopsies scored by multiple scorers. For single biopsies, the estimated correlation is 0.16 and 0.10, respectively. There are significant differences between the variance components for the two assays. For example, for log labeling index, PCNA has a lower variation between biopsies than BrdU, but higher variation between scorings. When used in a clinical or epidemiological setting, it is important to take multiple biopsies at multiple time points. Copyright (C) 2000 Elsevier Science Inc.

Original languageEnglish (US)
Pages (from-to)875-883
Number of pages9
JournalJournal of Clinical Epidemiology
Volume53
Issue number8
DOIs
StatePublished - Aug 2000
Externally publishedYes

Fingerprint

Proliferating Cell Nuclear Antigen
Bromodeoxyuridine
Mucous Membrane
Cell Proliferation
Biopsy
National Cancer Institute (U.S.)
Polyps
Analysis of Variance

Keywords

  • Biopsies
  • Colon adenomas
  • Colorectal cancer
  • Correlation
  • Variance components

ASJC Scopus subject areas

  • Medicine(all)
  • Public Health, Environmental and Occupational Health
  • Epidemiology

Cite this

Measuring cell proliferation in the rectal mucosa : Comparing bromodeoxyuridine (BrdU) and proliferating cell nuclear antigen (PCNA) assays. / Kulldorff, Martin; McShane, Lisa M.; Schatzkin, Arthur; Freedman, Laurence S.; Wargovich, Michael J; Woods, Cindy; Purewal, Madhu; Burt, Randall W.; Lawson, Michael; Mateski, Donna J.; Lanza, Elaine; Corle, Donald K.; O'Brien, Barbara; Moler, James.

In: Journal of Clinical Epidemiology, Vol. 53, No. 8, 08.2000, p. 875-883.

Research output: Contribution to journalArticle

Kulldorff, M, McShane, LM, Schatzkin, A, Freedman, LS, Wargovich, MJ, Woods, C, Purewal, M, Burt, RW, Lawson, M, Mateski, DJ, Lanza, E, Corle, DK, O'Brien, B & Moler, J 2000, 'Measuring cell proliferation in the rectal mucosa: Comparing bromodeoxyuridine (BrdU) and proliferating cell nuclear antigen (PCNA) assays', Journal of Clinical Epidemiology, vol. 53, no. 8, pp. 875-883. https://doi.org/10.1016/S0895-4356(99)00180-8
Kulldorff, Martin ; McShane, Lisa M. ; Schatzkin, Arthur ; Freedman, Laurence S. ; Wargovich, Michael J ; Woods, Cindy ; Purewal, Madhu ; Burt, Randall W. ; Lawson, Michael ; Mateski, Donna J. ; Lanza, Elaine ; Corle, Donald K. ; O'Brien, Barbara ; Moler, James. / Measuring cell proliferation in the rectal mucosa : Comparing bromodeoxyuridine (BrdU) and proliferating cell nuclear antigen (PCNA) assays. In: Journal of Clinical Epidemiology. 2000 ; Vol. 53, No. 8. pp. 875-883.
@article{6d253ac990764364acac8345199f785b,
title = "Measuring cell proliferation in the rectal mucosa: Comparing bromodeoxyuridine (BrdU) and proliferating cell nuclear antigen (PCNA) assays",
abstract = "Cell proliferation in the human colorectum can be measured using bromodeoxyuridine (BrdU) or proliferating cell nuclear antigen (PCNA) assays. Using data from the National Cancer Institute's Polyp Prevention Trial, these two assays are compared using correlation coefficients and variance components analysis. Adjusting for fixed as well as for the random effects of between-biopsy and scoring variation, the estimated correlation is 0.46 for the log labeling index and 0.45 for log proliferative height. This is an estimate of the highest correlation that can be achieved by taking multiple biopsies scored by multiple scorers. For single biopsies, the estimated correlation is 0.16 and 0.10, respectively. There are significant differences between the variance components for the two assays. For example, for log labeling index, PCNA has a lower variation between biopsies than BrdU, but higher variation between scorings. When used in a clinical or epidemiological setting, it is important to take multiple biopsies at multiple time points. Copyright (C) 2000 Elsevier Science Inc.",
keywords = "Biopsies, Colon adenomas, Colorectal cancer, Correlation, Variance components",
author = "Martin Kulldorff and McShane, {Lisa M.} and Arthur Schatzkin and Freedman, {Laurence S.} and Wargovich, {Michael J} and Cindy Woods and Madhu Purewal and Burt, {Randall W.} and Michael Lawson and Mateski, {Donna J.} and Elaine Lanza and Corle, {Donald K.} and Barbara O'Brien and James Moler",
year = "2000",
month = "8",
doi = "10.1016/S0895-4356(99)00180-8",
language = "English (US)",
volume = "53",
pages = "875--883",
journal = "Journal of Clinical Epidemiology",
issn = "0895-4356",
publisher = "Elsevier USA",
number = "8",

}

TY - JOUR

T1 - Measuring cell proliferation in the rectal mucosa

T2 - Comparing bromodeoxyuridine (BrdU) and proliferating cell nuclear antigen (PCNA) assays

AU - Kulldorff, Martin

AU - McShane, Lisa M.

AU - Schatzkin, Arthur

AU - Freedman, Laurence S.

AU - Wargovich, Michael J

AU - Woods, Cindy

AU - Purewal, Madhu

AU - Burt, Randall W.

AU - Lawson, Michael

AU - Mateski, Donna J.

AU - Lanza, Elaine

AU - Corle, Donald K.

AU - O'Brien, Barbara

AU - Moler, James

PY - 2000/8

Y1 - 2000/8

N2 - Cell proliferation in the human colorectum can be measured using bromodeoxyuridine (BrdU) or proliferating cell nuclear antigen (PCNA) assays. Using data from the National Cancer Institute's Polyp Prevention Trial, these two assays are compared using correlation coefficients and variance components analysis. Adjusting for fixed as well as for the random effects of between-biopsy and scoring variation, the estimated correlation is 0.46 for the log labeling index and 0.45 for log proliferative height. This is an estimate of the highest correlation that can be achieved by taking multiple biopsies scored by multiple scorers. For single biopsies, the estimated correlation is 0.16 and 0.10, respectively. There are significant differences between the variance components for the two assays. For example, for log labeling index, PCNA has a lower variation between biopsies than BrdU, but higher variation between scorings. When used in a clinical or epidemiological setting, it is important to take multiple biopsies at multiple time points. Copyright (C) 2000 Elsevier Science Inc.

AB - Cell proliferation in the human colorectum can be measured using bromodeoxyuridine (BrdU) or proliferating cell nuclear antigen (PCNA) assays. Using data from the National Cancer Institute's Polyp Prevention Trial, these two assays are compared using correlation coefficients and variance components analysis. Adjusting for fixed as well as for the random effects of between-biopsy and scoring variation, the estimated correlation is 0.46 for the log labeling index and 0.45 for log proliferative height. This is an estimate of the highest correlation that can be achieved by taking multiple biopsies scored by multiple scorers. For single biopsies, the estimated correlation is 0.16 and 0.10, respectively. There are significant differences between the variance components for the two assays. For example, for log labeling index, PCNA has a lower variation between biopsies than BrdU, but higher variation between scorings. When used in a clinical or epidemiological setting, it is important to take multiple biopsies at multiple time points. Copyright (C) 2000 Elsevier Science Inc.

KW - Biopsies

KW - Colon adenomas

KW - Colorectal cancer

KW - Correlation

KW - Variance components

UR - http://www.scopus.com/inward/record.url?scp=0033865947&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033865947&partnerID=8YFLogxK

U2 - 10.1016/S0895-4356(99)00180-8

DO - 10.1016/S0895-4356(99)00180-8

M3 - Article

VL - 53

SP - 875

EP - 883

JO - Journal of Clinical Epidemiology

JF - Journal of Clinical Epidemiology

SN - 0895-4356

IS - 8

ER -